CellFX Treat & Resect Low-Risk BCC Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 2, 2021

Primary Completion Date

March 2, 2022

Study Completion Date

July 22, 2022

Conditions
BCC - Basal Cell CarcinomaBCCExcision Margin
Interventions
DEVICE

CellFX System

Nano-Pulse Stimulation (NPS)

Trial Locations (5)

29407

Clinical Research Center of the Carolinas, Charleston

34685

Palm Harbor Dermatology, Clearwater

35242

Surgical Dermatology Group, Vestavia Hills

90210

Moy-Fincher-Chipps Dermatology, Beverly Hills

02467

SkinCare Physicians, Chestnut Hill

All Listed Sponsors
lead

Pulse Biosciences, Inc.

INDUSTRY